Туберкулоза (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Туберкулоза" in Serbian language version.

refsWebsite

Global rank Serbian rank

70nih.gov

4^th place

8^th place

51doi.org

2^nd place

4^th place

20google.ca

838^th place

391^st place

18web.archive.org

1^st place

14archive.org

6^th place

5^th place

8who.int

195^th place

154^th place

6cdc.gov

218^th place

138^th place

2nobelprize.org

301^st place

175^th place

2stoptb.org

low place

1emedicinehealth.com

8,799^th place

2,905^th place

1mayoclinic.com

3,634^th place

2,524^th place

1nice.org.uk

3,258^th place

1,880^th place

1phac-aspc.gc.ca

low place

1books.google.com

3^rd place

2^nd place

1wired.com

193^rd place

864^th place

1uchicago.edu

230^th place

217^th place

1mit.edu

415^th place

499^th place

1worldcat.org

5^th place

12^th place

1ceev.net

low place

1whonamedit.com

2,888^th place

3,693^rd place

1cnn.com

28^th place

89^th place

1archive.today

14^th place

22^nd place

1jrsm.org

low place

1nb.rs

3,800^th place

13^th place

1wkhealth.com

low place

3,674^th place

1reuters.com

49^th place

103^rd place

1hypothesisjournal.com

low place

1bepress.com

7,958^th place

low place

1globalhealth.org

low place

1scidev.net

low place

archive.org

Niemann, S.; et al. (2002). „Mycobacterium africanum Subtype II Is Associated with Two Distinct Genotypes and Is a Major Cause of Human Tuberculosis in Kampala, Uganda”. J. Clin. Microbiol. 40 (9): 3398—405. PMC 130701 . PMID 12202584. doi:10.1128/JCM.40.9.3398-3405.2002.
Niobe-Eyangoh SN; et al. (2003). „Genetic Biodiversity of Mycobacterium tuberculosis Complex Strains from Patients with Pulmonary Tuberculosis in Cameroon”. J. Clin. Microbiol. 41 (6): 2547—53. PMC 156567 . PMID 12791879. doi:10.1128/JCM.41.6.2547-2553.2003.
Chaisson, RE; Martinson, NA (13. 3. 2008). „Tuberculosis in Africa--combating an HIV-driven crisis”. The New England Journal of Medicine. 358 (11): 1089—92. PMID 18337598. doi:10.1056/NEJMp0800809.
Cole E, Cook C (1998). „Characterization of infectious aerosols in health care facilities: an aid to effective engineering controls and preventive strategies”. Am J Infect Control. 26 (4): 453—64. PMID 9721404. doi:10.1016/S0196-6553(98)70046-X.
Ahmed N, Hasnain S (2011). „Molecular epidemiology of tuberculosis in India: Moving forward with a systems biology approach”. Tuberculosis. 91 (5): 407—3. PMID 21514230. doi:10.1016/j.tube.2011.03.006.
Grosset, J. (2003). „Mycobacterium tuberculosis in the Extracellular Compartment: an Underestimated Adversary”. Antimicrob Agents Chemother. 47 (3): 833—6. PMC 149338 . PMID 12604509. doi:10.1128/AAC.47.3.833-836.2003.
Jacob, JT; Mehta, AK; Leonard, MK. „Acute forms of tuberculosis in adults.”. The American journal of medicine. 122 (1): 12—7. PMID 19114163.
Teo, SS; Shin gadia; DV. „Does BCG have a role in tuberculosis control and prevention in the United Kingdom?”. Archives of Disease in Childhood. 91 (6): 529—31. PMC 2082765 . PMID 16714729. doi:10.1136/adc.2005.085043.
Brennan PJ, Nikaido H (1995). „The envelope of mycobacteria”. Annu. Rev. Biochem. 64: 29—63. PMID 7574484. doi:10.1146/annurev.bi.64.070195.000333.
Wang, JY; et al. (15. 7. 2007). „Prediction of the tuberculosis reinfection proportion from the local incidence”. The Journal of infectious diseases. 196 (2): 281—8. PMID 17570116. doi:10.1086/518898.
Zink A, Sola C, Reischl U, Grabner W, Rastogi N, Wolf H, Nerlich A (2003). „Characterization of Mycobacterium tuberculosis Complex DNAs from Egyptian Mummies by Spoligotyping”. J Clin Microbiol. 41 (1): 359—67. PMC 149558 . PMID 12517873. doi:10.1128/JCM.41.1.359-367.2003.
Konomi N, Lebwohl E, Mowbray K, Tattersall I, Zhang D (2002). „Detection of Mycobacterial DNA in Andean Mummies”. J Clin Microbiol. 40 (12): 4738—40. PMC 154635 . PMID 12454182. doi:10.1128/JCM.40.12.4738-4740.2002.
Waddington, K. (јануар 2004). „To stamp out "So Terrible a Malady": bovine tuberculosis and tuberculin testing in Britain, 1890–1939”. Med Hist. 48 (1): 29—48. PMC 546294 . PMID 14968644. doi:10.1017/S0025727300007043.
Comstock, G. (1994). „The International Tuberculosis Campaign: a pioneering venture in mass vaccination and research”. Clinical Infectious Diseases. 19 (3): 528—40. PMID 7811874. doi:10.1093/clinids/19.3.528.

archive.today

McCarthy, O. R. (август 2001). „The key to the sanatoria”. J R Soc Med. 94 (8): 413—7. PMC 1281640 . PMID 11461990. Архивирано из оригинала 03. 08. 2012. г. Приступљено 14. 02. 2014.

bepress.com

Barder O, Kremer M, Williams H (2006). „Advance Market Commitments: A Policy to Stimulate Investment in Vaccines for Neglected Diseases”. The Economists' Voice. 3 (3). doi:10.2202/1553-3832.1144. Архивирано из оригинала 5. 11. 2006. г. Приступљено 14. 2. 2014.

books.google.com

Arch G.; Mainous, III (2010). Management of Antimicrobials in Infectious Diseases: Impact of Antibiotic Resistance. Humana Pr. стр. 69—. ISBN 978-1-60327-238-4.

cdc.gov

ATS/CDC Statement Committee on Latent Tuberculosis Infection (200). „Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society”. MMWR Recomm Rep. 49 (RR–6): 1—51. PMID 10881762.
„Core Curriculum on Tuberculosis: What the Clinician Should Know” (PDF) (5. изд.). Centers for Disease Control and Prevention (CDC), Division of Tuberculosis Elimination. 2011. стр. 24.
„Vaccine and Immunizations: TB Vaccine (BCG)”. Centers for Disease Control and Prevention. 2011. Архивирано из оригинала 17. 11. 2011. г. Приступљено 26. 7. 2011.
Centers for Disease Control and Prevention (CDC) (2006). „Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs—worldwide, 2000–2004”. Morbidity and Mortality Weekly Report. 55 (11): 301—5. PMID 16557213.
„Fact Sheets: The Difference Between Latent TB Infection and Active TB Disease”. Centers for Disease Control. 20. 6. 2011. Приступљено 26. 7. 2011.
Centers for Disease Control and Prevention (12. 9. 2006). „2005 Surveillance Slide Set”. Приступљено 13. 10. 2006.

ceev.net

Sledzik, Paul S.; Bellantoni, Nicholas. „Bioarcheological and biocultural evidence for the New England vampire folk belief” (PDF). American Journal of Physical Anthropology. 94 (2): 269—274. ISSN 0002-9483. PMID 8085617. doi:10.1002/ajpa.1330940210. Архивирано из оригинала (PDF) 4. 10. 2003. г. Приступљено 14. 2. 2014.

cnn.com

edition.cnn.com

{{cite web|author= |url=http://edition.cnn.com/2004/TRAVEL/DESTINATIONS/02/26/mammoth.cave.ap/index.html |title=date= |website= |publisher= |access-date=|archive-date=13. 08. 2006 |archive-url=https://web.archive.org/web/20060813140746/http://edition.cnn.com/2004/TRAVEL/DESTINATIONS/02/26/mammoth.cave.ap/index.html |url-status= }} CNN. 27. фебруар 2004. Приступљено сајту 8. октобра 2006.

doi.org

Lawn, SD; Zumla,, A. I. (2. 7. 2011). „Tuberculosis”. Lancet. 378 (9785): 57—72. PMID 21420161. doi:10.1016/S0140-6736(10)62173-3.
Madison, B. (2001). „Application of stains in clinical microbiology”. Biotech Histochem. 76 (3): 119—25. PMID 11475314. doi:10.1080/714028138.
Parish T, Stoker N (1999). „Mycobacteria: bugs and bugbears (two steps forward and one step back)”. Molecular Biotechnology. 13 (3): 191—200. PMID 10934532. doi:10.1385/MB:13:3:191.
van Soolingen D; et al. (1997). „A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa”. International Journal of Systematic Bacteriology. 47 (4): 1236—45. PMID 9336935. doi:10.1099/00207713-47-4-1236.
Niemann, S.; et al. (2002). „Mycobacterium africanum Subtype II Is Associated with Two Distinct Genotypes and Is a Major Cause of Human Tuberculosis in Kampala, Uganda”. J. Clin. Microbiol. 40 (9): 3398—405. PMC 130701 . PMID 12202584. doi:10.1128/JCM.40.9.3398-3405.2002.
Niobe-Eyangoh SN; et al. (2003). „Genetic Biodiversity of Mycobacterium tuberculosis Complex Strains from Patients with Pulmonary Tuberculosis in Cameroon”. J. Clin. Microbiol. 41 (6): 2547—53. PMC 156567 . PMID 12791879. doi:10.1128/JCM.41.6.2547-2553.2003.
Thoen C, Lobue P, de Kantor I (2006). „The importance of Mycobacterium bovis as a zoonosis”. Vet. Microbiol. 112 (2–4): 339—45. PMID 16387455. doi:10.1016/j.vetmic.2005.11.047.
Chaisson, RE; Martinson, NA (13. 3. 2008). „Tuberculosis in Africa--combating an HIV-driven crisis”. The New England Journal of Medicine. 358 (11): 1089—92. PMID 18337598. doi:10.1056/NEJMp0800809.
Griffith D, Kerr C (1996). „Tuberculosis: disease of the past, disease of the present”. J Perianesth Nurs. 11 (4): 240—5. PMID 8964016. doi:10.1016/S1089-9472(96)80023-2.
Restrepo, BI (15. 8. 2007). „Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances”. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 45 (4): 436—8. PMC 2900315 . PMID 17638190. doi:10.1086/519939.
Möller, M; Hoal, EG. „Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis”. Tuberculosis (Edinburgh, Scotland). 90 (2): 71—83. PMID 20206579. doi:10.1016/j.tube.2010.02.002.
Cole E, Cook C (1998). „Characterization of infectious aerosols in health care facilities: an aid to effective engineering controls and preventive strategies”. Am J Infect Control. 26 (4): 453—64. PMID 9721404. doi:10.1016/S0196-6553(98)70046-X.
Nicas M, Nazaroff WW, Hubbard A (2005). „Toward understanding the risk of secondary airborne infection: emission of respirable pathogens”. J Occup Environ Hyg. 2 (3): 143—54. PMID 15764538. doi:10.1080/15459620590918466.
Ahmed N, Hasnain S (2011). „Molecular epidemiology of tuberculosis in India: Moving forward with a systems biology approach”. Tuberculosis. 91 (5): 407—3. PMID 21514230. doi:10.1016/j.tube.2011.03.006.
Houben E, Nguyen L, Pieters J (2006). „Interaction of pathogenic mycobacteria with the host immune system”. Curr Opin Microbiol. 9 (1): 76—85. PMID 16406837. doi:10.1016/j.mib.2005.12.014.
Herrmann J, Lagrange P (2005). „Dendritic cells and Mycobacterium tuberculosis: which is the Trojan horse?”. Pathol Biol (Paris). 53 (1): 35—40. PMID 15620608. doi:10.1016/j.patbio.2004.01.004.
Agarwal R, Malhotra P, Awasthi A, Kakkar N, Gupta D (2005). „Tuberculous dilated cardiomyopathy: an under-recognized entity?”. BMC Infect Dis. 5 (1): 29—. PMC 1090580 . PMID 15857515. doi:10.1186/1471-2334-5-29.
Grosset, J. (2003). „Mycobacterium tuberculosis in the Extracellular Compartment: an Underestimated Adversary”. Antimicrob Agents Chemother. 47 (3): 833—6. PMC 149338 . PMID 12604509. doi:10.1128/AAC.47.3.833-836.2003.
Steingart, KR; et al. „Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis.”. PLoS medicine. 8 (8): e1001062. PMC 3153457 . PMID 21857806. doi:10.1371/journal.pmed.1001062.
Rothel J, Andersen P (2005). „Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?”. Expert Rev Anti Infect Ther. 3 (6): 981—93. PMID 16307510. doi:10.1586/14787210.3.6.981.
McShane, H (12. 10. 2011). „Tuberculosis vaccines: beyond bacille Calmette–Guérin”. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 366 (1579): 2782—9. PMC 3146779 . PMID 21893541. doi:10.1098/rstb.2011.0097.
Teo, SS; Shin gadia; DV. „Does BCG have a role in tuberculosis control and prevention in the United Kingdom?”. Archives of Disease in Childhood. 91 (6): 529—31. PMC 2082765 . PMID 16714729. doi:10.1136/adc.2005.085043.
Brennan PJ, Nikaido H (1995). „The envelope of mycobacteria”. Annu. Rev. Biochem. 64: 29—63. PMID 7574484. doi:10.1146/annurev.bi.64.070195.000333.
Volmink J, Garner P (2007). Volmink J, ур. „Directly observed therapy for treating tuberculosis”. Cochrane Database Syst Rev (4): CD003343. PMID 17943789. doi:10.1002/14651858.CD003343.pub3.
Liu, Q; et al. (2008 10. 8). Liu, Qin, ур. „Reminder systems and late patient tracers in the diagnosis and management of tuberculosis.”. Cochrane Database of Systematic Reviews (Online) (4): CD006594. PMID 18843723. doi:10.1002/14651858.CD006594.pub2. Проверите вредност парамет(а)ра за датум: |date= (помоћ)
Lambert, M.; et al. (2003). „Recurrence in tuberculosis: relapse or reinfection?”. Lancet Infect Dis. 3 (5): 282—7. PMID 12726976. doi:10.1016/S1473-3099(03)00607-8.
Wang, JY; et al. (15. 7. 2007). „Prediction of the tuberculosis reinfection proportion from the local incidence”. The Journal of infectious diseases. 196 (2): 281—8. PMID 17570116. doi:10.1086/518898.
Rothschild, B. M.; Martin, L. D.; Lev, G.; et al. (август 2001). „Mycobacterium tuberculosis complex DNA from an extinct bison dated 17,000 years before the present”. Clinical Infectious Diseases. 33 (3): 305—11. PMID 11438894. doi:10.1086/321886.
Pearce-Duvet J (2006). „The origin of human pathogens: evaluating the role of agriculture and domestic animals in the evolution of human disease”. Biol Rev Camb Philos Soc. 81 (3): 369—82. PMID 16672105. doi:10.1017/S1464793106007020.
Comas, I; Gagneux, S. Manchester, Marianne, ур. „The past and future of tuberculosis research”. PLoS Pathogens. 5 (10): e1000600. PMC 2745564 . PMID 19855821. doi:10.1371/journal.ppat.1000600.
Zink A, Sola C, Reischl U, Grabner W, Rastogi N, Wolf H, Nerlich A (2003). „Characterization of Mycobacterium tuberculosis Complex DNAs from Egyptian Mummies by Spoligotyping”. J Clin Microbiol. 41 (1): 359—67. PMC 149558 . PMID 12517873. doi:10.1128/JCM.41.1.359-367.2003.
Konomi N, Lebwohl E, Mowbray K, Tattersall I, Zhang D (2002). „Detection of Mycobacterial DNA in Andean Mummies”. J Clin Microbiol. 40 (12): 4738—40. PMC 154635 . PMID 12454182. doi:10.1128/JCM.40.12.4738-4740.2002.
Sledzik, Paul S.; Bellantoni, Nicholas. „Bioarcheological and biocultural evidence for the New England vampire folk belief” (PDF). American Journal of Physical Anthropology. 94 (2): 269—274. ISSN 0002-9483. PMID 8085617. doi:10.1002/ajpa.1330940210. Архивирано из оригинала (PDF) 4. 10. 2003. г. Приступљено 14. 2. 2014.
Trail, R. R. (април 1970). „Richard Morton (1637-1698)”. Med Hist. 14 (2): 166—74. PMC 1034037 . PMID 4914685. doi:10.1017/S0025727300015350.
Waddington, K. (јануар 2004). „To stamp out "So Terrible a Malady": bovine tuberculosis and tuberculin testing in Britain, 1890–1939”. Med Hist. 48 (1): 29—48. PMC 546294 . PMID 14968644. doi:10.1017/S0025727300007043.
Bonah, C. (2005). „The 'experimental stable' of the BCG vaccine: safety, efficacy, proof, and standards, 1921–1933”. Stud Hist Philos Biol Biomed Sci. 36 (4): 696—721. PMID 16337557. doi:10.1016/j.shpsc.2005.09.003.
Comstock, G. (1994). „The International Tuberculosis Campaign: a pioneering venture in mass vaccination and research”. Clinical Infectious Diseases. 19 (3): 528—40. PMID 7811874. doi:10.1093/clinids/19.3.528.
Lalloo UG, Naidoo R, Ambaram A (мај 2006). „Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis”. Curr Opin Pulm Med. 12 (3): 179—85. PMID 16582672. doi:10.1097/01.mcp.0000219266.27439.52. Архивирано из оригинала 10. 05. 2013. г. Приступљено 14. 02. 2014.
Lawn, SD; Nicol, MP. „Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance”. Future microbiology. 6 (9): 1067—82. PMC 3252681 . PMID 21958145. doi:10.2217/fmb.11.84.
Lienhardt, C; et al. „What research is needed to stop TB? Introducing the TB Research Movement”. PLoS medicine. 8 (11): e1001135. PMC 3226454 . PMID 22140369. doi:10.1371/journal.pmed.1001135.
Amdekar, Y. „Changes in the management of tuberculosis”. Indian journal of pediatrics. 76 (7): 739—42. PMID 19693453. doi:10.1007/s12098-009-0164-4.
Martín Montañés, C; Gicquel, B. „New tuberculosis vaccines”. Enfermedades infecciosas y microbiologia clinica. 29 Su: 1,57—62. PMID 21420568. doi:10.1016/S0213-005X(11)70019-2.
Ibanga H, Brookes R, Hill P, Owiafe P, Fletcher H, Lienhardt C, Hill A, Adegbola R, McShane H (2006). „Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design”. Lancet Infect Dis. 6 (8): 522—8. PMID 16870530. doi:10.1016/S1473-3099(06)70552-7.
Kaufmann, SH (2010). „Future vaccination strategies against tuberculosis: Thinking outside the box”. Immunity. 33 (4): 567—77. PMID 21029966. doi:10.1016/j.immuni.2010.09.015.
Barder O, Kremer M, Williams H (2006). „Advance Market Commitments: A Policy to Stimulate Investment in Vaccines for Neglected Diseases”. The Economists' Voice. 3 (3). doi:10.2202/1553-3832.1144. Архивирано из оригинала 5. 11. 2006. г. Приступљено 14. 2. 2014.
Shivaprasad, HL; Palmieri, C. „Pathology of mycobacteriosis in birds”. The veterinary clinics of North America. Exotic animal practice. 15 (1): 41—55,v—vi. PMID 22244112. doi:10.1016/j.cvex.2011.11.004.
Reavill, DR; Schmidt, RE. „Mycobacterial lesions in fish, amphibians, reptiles, rodents, lagomorphs, and ferrets with reference to animal models”. The veterinary clinics of North America. Exotic animal practice. 15 (1): 25—40,v. PMID 22244111. doi:10.1016/j.cvex.2011.10.001.
Mitchell, MA. „Mycobacterial infections in reptiles”. The veterinary clinics of North America. Exotic animal practice. 15 (1): 101—11,vii. PMID 22244116. doi:10.1016/j.cvex.2011.10.002.
Ryan, TJ; et al. (25. 2. 2006). „Advances in understanding disease epidemiology and implications for control and eradication of tuberculosis in livestock: the experience from New Zealand”. Veterinary microbiology. 112 (2–4): 211—9. PMID 16330161. doi:10.1016/j.vetmic.2005.11.025.
White, PC; et al. „Control of bovine tuberculosis in British livestock: there is no 'silver bullet'”. Trends in microbiology. 16 (9): 420—7. PMID 18706814. doi:10.1016/j.tim.2008.06.005.
Ward, AI; et al. (1. 1. 2010). „Farm husbandry and badger behaviour: opportunities to manage badger to cattle transmission of Mycobacterium bovis?”. Preventive veterinary medicine. 93 (1): 2—10. PMID 19846226. doi:10.1016/j.prevetmed.2009.09.014.

emedicinehealth.com

Schiffman, G (15. 1. 2009). „Tuberculosis Symptoms”. eMedicineHealth.

globalhealth.org

Bill and Melinda Gates Foundation Announcement (2004). „Gates Foundation Commits $82.9 Million to Develop New Tuberculosis Vaccines”. Архивирано из оригинала 10. 10. 2009. г. Приступљено 14. 02. 2014.

google.ca

books.google.ca

Behera 2010, стр. 457. Behera, D. (2010). Textbook of pulmonary medicine (2. изд.). New Delhi: Jaypee Brothers Medical Pub. стр. 457—. ISBN 978-81-8448-749-7. Архивирано из оригинала 18. 7. 2013. г. Приступљено 14. 2. 2014.
Jindal 2011, стр. 549. Jindal, editor-in-chief SK (2011). Textbook of pulmonary and critical care medicine. New Delhi: Jaypee Brothers Medical Publishers. стр. 549—. ISBN 978-93-5025-073-0.
Kabra 2006, стр. 249 Kabra, Vimlesh Seth, S.K., ур. (2006). Essentials of tuberculosis in children (3. изд.). New Delhi: Jaypee Bros. Medical Publishers. стр. 249—. ISBN 978-81-8061-709-6. Архивирано из оригинала 10. 11. 2014. г. Приступљено 14. 02. 2014.
Medical Laboratory Science: Theory and Practice. New Delhi: Tata McGraw-Hill. 2000. стр. 473—. ISBN 978-0-07-463223-9.
Acton 2011, стр. 1968. Acton, Q. Ashton (2011). Mycobacterium Infections: New Insights for the Healthcare Professional. ScholarlyEditions. стр. 1968—. ISBN 978-1-4649-0122-5.
Skolnik 2011, стр. 253 Skolnik, Richard (2011). Global health 101 (2. изд.). Burlington, MA: Jones & Bartlett Learning. стр. 253—. ISBN 978-0-7637-9751-5.
Khan 2011, стр. 401. Khan (2011). Essence Of Paediatrics. Elsevier India. стр. 401—. ISBN 978-81-312-2804-3.
Crowley 2010, стр. 374. Crowley, Leonard V. (2010). An introduction to human disease : pathology and pathophysiology correlations (8. изд.). Sudbury, Mass.: Jones and Bartlett. стр. 374—. ISBN 978-0-7637-6591-0.
Anthony 2005, стр. 75. Anthony, Harries (2005). TB/HIV a Clinical Manual (2. изд.). Geneva: World Health Organization. стр. 75—. ISBN 978-92-4-154634-8.
Diseases 2006, стр. 36. Diseases, Special Programme for Research & Training in Tropical (2006). Diagnostics for tuberculosis: global demand and market potential. Geneva: World Health Organization on behalf of the Special Programme for Research and Training in Tropical Diseases. стр. 36—. ISBN 978-92-4-156330-7.
Jindal, SK. Textbook of pulmonary and critical care medicine. New Delhi: Jaypee Brothers Medical Publishers. стр. 544—. ISBN 978-93-5025-073-0.
Warrell 2005, стр. 560. Warrell, ed. by D. J. Weatherall ... [4. + 5. ed.] ed. by David A. (2005). Sections 1 - 10. (4. paperback. изд.). Oxford [u.a.]: Oxford University Press. стр. 560. ISBN 978-0-19-857014-1.
Quah et al. 2009, стр. 424– Quah, Stella R.; Carrin, Guy; Buse, Kent; Heggenhougen, Kristian (2009). Health Systems Policy, Finance, and Organization. Boston: Academic Press. стр. 424. ISBN 978-0-12-375087-7.
Anne-Emanuelle Birn (2009). Textbook of International Health: Global Health in a Dynamic World. стр. 261—. ISBN 978-0-19-988521-3.
The Chambers Dictionary. New Delhi: Allied Chambers India Ltd. 1998. стр. 352—. ISBN 978-81-86062-25-8.
Persson 2010, стр. 141. Persson, Sheryl (2010). Smallpox, Syphilis and Salvation: Medical Breakthroughs That Changed the World. ReadHowYouWant.com. стр. 141—. ISBN 978-1-4587-6712-7.
Hannaway 2008, стр. 233. Hannaway, Caroline, ур. (2008). Biomedicine in the twentieth century: practices, policies, and politics. Amsterdam: IOS Press. стр. 233—. ISBN 978-1-58603-832-8.
Shields 2009, стр. 792. Shields, Thomas (2009). General thoracic surgery (7. изд.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. стр. 792—. ISBN 978-0-7817-7982-1.
Zuckerman & Jong 2010, стр. 319. Zuckerman, Jane N.; Jong, Elaine C., ур. (2010). Travelers' vaccines (2. изд.). Shelton, CT: People's Medical Pub. House. стр. 319—. ISBN 978-1-60795-045-5.
Wobeser 2006, стр. 170. Wobeser, Gary A. (2006). Essentials of disease in wild animals (1. изд.). Ames, Iowa [u.a.]: Blackwell Publ. стр. 170—. ISBN 978-0-8138-0589-4.

hypothesisjournal.com

Bhargava, Anurag; Pinto, Lancelot; Pai, Madhukar (2011). „Mismanagement of tuberculosis in India: Causes, consequences, and the way forward”. Hypothesis. 9 (1): e7. Архивирано из оригинала 12. 01. 2020. г. Приступљено 14. 02. 2014.

jrsm.org

McCarthy, O. R. (август 2001). „The key to the sanatoria”. J R Soc Med. 94 (8): 413—7. PMC 1281640 . PMID 11461990. Архивирано из оригинала 03. 08. 2012. г. Приступљено 14. 02. 2014.

mayoclinic.com

„Causes of Tuberculosis”. Mayo Clinic. 2006. Приступљено 19. 10. 2007.

mit.edu

classics.mit.edu

Hippocrates. „Aphorisms.”. Архивирано из оригинала 2005-02-11. г. Приступљено 7. октобра 2006. Проверите вредност парамет(а)ра за датум: |access-date= (помоћ)

nb.rs

digitalna.nb.rs

"Политика", 15. нов. 1936

nice.org.uk

guidance.nice.org.uk

National Institute for Health and Clinical Excellence. Clinical guideline 117: Tuberculosis. London, 2011.

nih.gov

ncbi.nlm.nih.gov

Lawn, SD; Zumla,, A. I. (2. 7. 2011). „Tuberculosis”. Lancet. 378 (9785): 57—72. PMID 21420161. doi:10.1016/S0140-6736(10)62173-3.
Golden MP, Vikram HR (2005). „Extrapulmonary tuberculosis: an overview”. American Family Physician. 72 (9): 1761—8. PMID 16300038.
Madison, B. (2001). „Application of stains in clinical microbiology”. Biotech Histochem. 76 (3): 119—25. PMID 11475314. doi:10.1080/714028138.
Parish T, Stoker N (1999). „Mycobacteria: bugs and bugbears (two steps forward and one step back)”. Molecular Biotechnology. 13 (3): 191—200. PMID 10934532. doi:10.1385/MB:13:3:191.
van Soolingen D; et al. (1997). „A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa”. International Journal of Systematic Bacteriology. 47 (4): 1236—45. PMID 9336935. doi:10.1099/00207713-47-4-1236.
Niemann, S.; et al. (2002). „Mycobacterium africanum Subtype II Is Associated with Two Distinct Genotypes and Is a Major Cause of Human Tuberculosis in Kampala, Uganda”. J. Clin. Microbiol. 40 (9): 3398—405. PMC 130701 . PMID 12202584. doi:10.1128/JCM.40.9.3398-3405.2002.
Niobe-Eyangoh SN; et al. (2003). „Genetic Biodiversity of Mycobacterium tuberculosis Complex Strains from Patients with Pulmonary Tuberculosis in Cameroon”. J. Clin. Microbiol. 41 (6): 2547—53. PMC 156567 . PMID 12791879. doi:10.1128/JCM.41.6.2547-2553.2003.
Thoen C, Lobue P, de Kantor I (2006). „The importance of Mycobacterium bovis as a zoonosis”. Vet. Microbiol. 112 (2–4): 339—45. PMID 16387455. doi:10.1016/j.vetmic.2005.11.047.
Pfyffer, GE; et al. „Mycobacterium canettii, the smooth variant of M. tuberculosis, isolated from a Swiss patient exposed in Africa.”. Emerging infectious diseases. 4 (4): 631—4. PMID 9866740.
Panteix, G; et al. „Pulmonary tuberculosis due to Mycobacterium microti: a study of six recent cases in France.”. Journal of medical microbiology. 59 (Pt 8): 984—9. PMID 20488936.
American Thoracic Society (1997). „Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association”. American Journal of Respiratory and Critical Care Medicine. 156 (2 Pt 2): S1—25. PMID 9279284.
Chaisson, RE; Martinson, NA (13. 3. 2008). „Tuberculosis in Africa--combating an HIV-driven crisis”. The New England Journal of Medicine. 358 (11): 1089—92. PMID 18337598. doi:10.1056/NEJMp0800809.
Griffith D, Kerr C (1996). „Tuberculosis: disease of the past, disease of the present”. J Perianesth Nurs. 11 (4): 240—5. PMID 8964016. doi:10.1016/S1089-9472(96)80023-2.
ATS/CDC Statement Committee on Latent Tuberculosis Infection (200). „Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society”. MMWR Recomm Rep. 49 (RR–6): 1—51. PMID 10881762.
van Zyl Smit, RN; et al. „Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD.”. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology. 35 (1): 27—33. PMID 20044459. „These analyses indicate that smokers are almost twice as likely to be infected with TB and to progress to active disease (RR of ∼1.5 for latent TB infection (LTBI) and RR of ∼2.0 for TB disease). Smokers are also twice as likely to die from TB (RR of ∼2.0 for TB mortality), but data are difficult to interpret because of heterogeneity in the results across studies.”
Restrepo, BI (15. 8. 2007). „Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances”. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 45 (4): 436—8. PMC 2900315 . PMID 17638190. doi:10.1086/519939.
Möller, M; Hoal, EG. „Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis”. Tuberculosis (Edinburgh, Scotland). 90 (2): 71—83. PMID 20206579. doi:10.1016/j.tube.2010.02.002.
Cole E, Cook C (1998). „Characterization of infectious aerosols in health care facilities: an aid to effective engineering controls and preventive strategies”. Am J Infect Control. 26 (4): 453—64. PMID 9721404. doi:10.1016/S0196-6553(98)70046-X.
Nicas M, Nazaroff WW, Hubbard A (2005). „Toward understanding the risk of secondary airborne infection: emission of respirable pathogens”. J Occup Environ Hyg. 2 (3): 143—54. PMID 15764538. doi:10.1080/15459620590918466.
Ahmed N, Hasnain S (2011). „Molecular epidemiology of tuberculosis in India: Moving forward with a systems biology approach”. Tuberculosis. 91 (5): 407—3. PMID 21514230. doi:10.1016/j.tube.2011.03.006.
Houben E, Nguyen L, Pieters J (2006). „Interaction of pathogenic mycobacteria with the host immune system”. Curr Opin Microbiol. 9 (1): 76—85. PMID 16406837. doi:10.1016/j.mib.2005.12.014.
Herrmann J, Lagrange P (2005). „Dendritic cells and Mycobacterium tuberculosis: which is the Trojan horse?”. Pathol Biol (Paris). 53 (1): 35—40. PMID 15620608. doi:10.1016/j.patbio.2004.01.004.
Agarwal R, Malhotra P, Awasthi A, Kakkar N, Gupta D (2005). „Tuberculous dilated cardiomyopathy: an under-recognized entity?”. BMC Infect Dis. 5 (1): 29—. PMC 1090580 . PMID 15857515. doi:10.1186/1471-2334-5-29.
Grosset, J. (2003). „Mycobacterium tuberculosis in the Extracellular Compartment: an Underestimated Adversary”. Antimicrob Agents Chemother. 47 (3): 833—6. PMC 149338 . PMID 12604509. doi:10.1128/AAC.47.3.833-836.2003.
Jacob, JT; Mehta, AK; Leonard, MK. „Acute forms of tuberculosis in adults.”. The American journal of medicine. 122 (1): 12—7. PMID 19114163.
Bento, J; et al. „Diagnostic tools in tuberculosis”. Acta medica portuguesa. 24 (1): 145—54. PMID 21672452.
Escalante, P (2009 6. 2). „In the clinic. Tuberculosis.”. Annals of internal medicine. 150 (11): ITC61—614; quiz ITV616. PMID 19487708. Проверите вредност парамет(а)ра за датум: |date= (помоћ)
Metcalfe, JZ; et al. „Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis.”. The Journal of infectious diseases. 204 Su: S1120—9,4. PMID 21996694.
Sester, M; et al. „Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis.”. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 37 (1): 100—11. PMID 20847080.
Chen; et al. (2011). „Interferon-gamma release assays for the diagnosis of active tuberculosis in HIV-infected patients: a systematic review and meta-analysis.”. PloS one. 6 (11): e26827. PMID 22069472.
Sester, M; et al. „Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis.”. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 37 (1): 100—11. PMID 20847080.
Steingart, KR; et al. „Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis.”. PLoS medicine. 8 (8): e1001062. PMC 3153457 . PMID 21857806. doi:10.1371/journal.pmed.1001062.
Rothel J, Andersen P (2005). „Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?”. Expert Rev Anti Infect Ther. 3 (6): 981—93. PMID 16307510. doi:10.1586/14787210.3.6.981.
Pai M, Zwerling A, Menzies D (2008). „Systematic Review: T-Cell–based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update”. Annals of Internal Medicine. 149 (3): 1—9. PMC 2951987 . PMID 18593687.
Amicosante, M; Ciccozzi, M; Markova, R. „Rational use of immunodiagnostic tools for tuberculosis infection: guidelines and cost effectiveness studies.”. The new microbiologica. 33 (2): 93—107. PMID 20518271.
McShane, H (12. 10. 2011). „Tuberculosis vaccines: beyond bacille Calmette–Guérin”. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 366 (1579): 2782—9. PMC 3146779 . PMID 21893541. doi:10.1098/rstb.2011.0097.
Teo, SS; Shin gadia; DV. „Does BCG have a role in tuberculosis control and prevention in the United Kingdom?”. Archives of Disease in Childhood. 91 (6): 529—31. PMC 2082765 . PMID 16714729. doi:10.1136/adc.2005.085043.
Brennan PJ, Nikaido H (1995). „The envelope of mycobacteria”. Annu. Rev. Biochem. 64: 29—63. PMID 7574484. doi:10.1146/annurev.bi.64.070195.000333.
Menzies, D; et al. „Recent developments in treatment of latent tuberculosis infection.”. The Indian Journal of Medical Research. 133 (3): 257—66. PMC 3103149 . PMID 21441678.
Volmink J, Garner P (2007). Volmink J, ур. „Directly observed therapy for treating tuberculosis”. Cochrane Database Syst Rev (4): CD003343. PMID 17943789. doi:10.1002/14651858.CD003343.pub3.
Liu, Q; et al. (2008 10. 8). Liu, Qin, ур. „Reminder systems and late patient tracers in the diagnosis and management of tuberculosis.”. Cochrane Database of Systematic Reviews (Online) (4): CD006594. PMID 18843723. doi:10.1002/14651858.CD006594.pub2. Проверите вредност парамет(а)ра за датум: |date= (помоћ)
O'Brien R (1994). „Drug-resistant tuberculosis: etiology, management and prevention”. Semin Respir Infect. 9 (2): 104—12. PMID 7973169.
Centers for Disease Control and Prevention (CDC) (2006). „Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs—worldwide, 2000–2004”. Morbidity and Mortality Weekly Report. 55 (11): 301—5. PMID 16557213.
Lambert, M.; et al. (2003). „Recurrence in tuberculosis: relapse or reinfection?”. Lancet Infect Dis. 3 (5): 282—7. PMID 12726976. doi:10.1016/S1473-3099(03)00607-8.
Wang, JY; et al. (15. 7. 2007). „Prediction of the tuberculosis reinfection proportion from the local incidence”. The Journal of infectious diseases. 196 (2): 281—8. PMID 17570116. doi:10.1086/518898.
FitzGerald, JM; et al. „Tuberculosis: 13. Control of the disease among aboriginal people in Canada.”. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 162 (3): 351—5. PMID 10693593.
Rothschild, B. M.; Martin, L. D.; Lev, G.; et al. (август 2001). „Mycobacterium tuberculosis complex DNA from an extinct bison dated 17,000 years before the present”. Clinical Infectious Diseases. 33 (3): 305—11. PMID 11438894. doi:10.1086/321886.
Pearce-Duvet J (2006). „The origin of human pathogens: evaluating the role of agriculture and domestic animals in the evolution of human disease”. Biol Rev Camb Philos Soc. 81 (3): 369—82. PMID 16672105. doi:10.1017/S1464793106007020.
Comas, I; Gagneux, S. Manchester, Marianne, ур. „The past and future of tuberculosis research”. PLoS Pathogens. 5 (10): e1000600. PMC 2745564 . PMID 19855821. doi:10.1371/journal.ppat.1000600.
Zink A, Sola C, Reischl U, Grabner W, Rastogi N, Wolf H, Nerlich A (2003). „Characterization of Mycobacterium tuberculosis Complex DNAs from Egyptian Mummies by Spoligotyping”. J Clin Microbiol. 41 (1): 359—67. PMC 149558 . PMID 12517873. doi:10.1128/JCM.41.1.359-367.2003.
Konomi N, Lebwohl E, Mowbray K, Tattersall I, Zhang D (2002). „Detection of Mycobacterial DNA in Andean Mummies”. J Clin Microbiol. 40 (12): 4738—40. PMC 154635 . PMID 12454182. doi:10.1128/JCM.40.12.4738-4740.2002.
Sledzik, Paul S.; Bellantoni, Nicholas. „Bioarcheological and biocultural evidence for the New England vampire folk belief” (PDF). American Journal of Physical Anthropology. 94 (2): 269—274. ISSN 0002-9483. PMID 8085617. doi:10.1002/ajpa.1330940210. Архивирано из оригинала (PDF) 4. 10. 2003. г. Приступљено 14. 2. 2014.
Trail, R. R. (април 1970). „Richard Morton (1637-1698)”. Med Hist. 14 (2): 166—74. PMC 1034037 . PMID 4914685. doi:10.1017/S0025727300015350.
McCarthy, O. R. (август 2001). „The key to the sanatoria”. J R Soc Med. 94 (8): 413—7. PMC 1281640 . PMID 11461990. Архивирано из оригинала 03. 08. 2012. г. Приступљено 14. 02. 2014.
Waddington, K. (јануар 2004). „To stamp out "So Terrible a Malady": bovine tuberculosis and tuberculin testing in Britain, 1890–1939”. Med Hist. 48 (1): 29—48. PMC 546294 . PMID 14968644. doi:10.1017/S0025727300007043.
Bonah, C. (2005). „The 'experimental stable' of the BCG vaccine: safety, efficacy, proof, and standards, 1921–1933”. Stud Hist Philos Biol Biomed Sci. 36 (4): 696—721. PMID 16337557. doi:10.1016/j.shpsc.2005.09.003.
Comstock, G. (1994). „The International Tuberculosis Campaign: a pioneering venture in mass vaccination and research”. Clinical Infectious Diseases. 19 (3): 528—40. PMID 7811874. doi:10.1093/clinids/19.3.528.
Lalloo UG, Naidoo R, Ambaram A (мај 2006). „Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis”. Curr Opin Pulm Med. 12 (3): 179—85. PMID 16582672. doi:10.1097/01.mcp.0000219266.27439.52. Архивирано из оригинала 10. 05. 2013. г. Приступљено 14. 02. 2014.
Lawn, SD; Nicol, MP. „Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance”. Future microbiology. 6 (9): 1067—82. PMC 3252681 . PMID 21958145. doi:10.2217/fmb.11.84.
Lienhardt, C; et al. „What research is needed to stop TB? Introducing the TB Research Movement”. PLoS medicine. 8 (11): e1001135. PMC 3226454 . PMID 22140369. doi:10.1371/journal.pmed.1001135.
Amdekar, Y. „Changes in the management of tuberculosis”. Indian journal of pediatrics. 76 (7): 739—42. PMID 19693453. doi:10.1007/s12098-009-0164-4.
Martín Montañés, C; Gicquel, B. „New tuberculosis vaccines”. Enfermedades infecciosas y microbiologia clinica. 29 Su: 1,57—62. PMID 21420568. doi:10.1016/S0213-005X(11)70019-2.
Ibanga H, Brookes R, Hill P, Owiafe P, Fletcher H, Lienhardt C, Hill A, Adegbola R, McShane H (2006). „Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design”. Lancet Infect Dis. 6 (8): 522—8. PMID 16870530. doi:10.1016/S1473-3099(06)70552-7.
Kaufmann, SH (2010). „Future vaccination strategies against tuberculosis: Thinking outside the box”. Immunity. 33 (4): 567—77. PMID 21029966. doi:10.1016/j.immuni.2010.09.015.
Shivaprasad, HL; Palmieri, C. „Pathology of mycobacteriosis in birds”. The veterinary clinics of North America. Exotic animal practice. 15 (1): 41—55,v—vi. PMID 22244112. doi:10.1016/j.cvex.2011.11.004.
Reavill, DR; Schmidt, RE. „Mycobacterial lesions in fish, amphibians, reptiles, rodents, lagomorphs, and ferrets with reference to animal models”. The veterinary clinics of North America. Exotic animal practice. 15 (1): 25—40,v. PMID 22244111. doi:10.1016/j.cvex.2011.10.001.
Mitchell, MA. „Mycobacterial infections in reptiles”. The veterinary clinics of North America. Exotic animal practice. 15 (1): 101—11,vii. PMID 22244116. doi:10.1016/j.cvex.2011.10.002.
Ryan, TJ; et al. (25. 2. 2006). „Advances in understanding disease epidemiology and implications for control and eradication of tuberculosis in livestock: the experience from New Zealand”. Veterinary microbiology. 112 (2–4): 211—9. PMID 16330161. doi:10.1016/j.vetmic.2005.11.025.
White, PC; et al. „Control of bovine tuberculosis in British livestock: there is no 'silver bullet'”. Trends in microbiology. 16 (9): 420—7. PMID 18706814. doi:10.1016/j.tim.2008.06.005.
Ward, AI; et al. (1. 1. 2010). „Farm husbandry and badger behaviour: opportunities to manage badger to cattle transmission of Mycobacterium bovis?”. Preventive veterinary medicine. 93 (1): 2—10. PMID 19846226. doi:10.1016/j.prevetmed.2009.09.014.

nobelprize.org

„The Nobel Prize in Physiology or Medicine 1905.”. Приступљено 7. 10. 2006. ,.
Nobel Foundation. The Nobel Prize in Physiology or Medicine 1905. Приступљено сајту 7. октобра 2006.

phac-aspc.gc.ca

„BCG Vaccine Usage in Canada -Current and Historical”. Public Health Agency of Canada. 2010. Архивирано из оригинала 30. 3. 2012. г. Приступљено 30. 12. 2011.

reuters.com

„WHO says Cepheid rapid test will transform TB care”. Reuters. 8. 12. 2010.

scidev.net

Nightingale, Katherine (2007). „Gates foundation gives US$280 million to fight TB”.

stoptb.org

„The Global Plan to Stop TB”. World Health Organization. 2011. Архивирано из оригинала 12. 06. 2011. г. Приступљено 13. 6. 2011.
STOPTB (5. 4. 2013). „The Stop TB Partnership, which operates through a secretariat hosted by the World Health Organization (WHO) in Geneva, Switzerland.” (pdf).

uchicago.edu

journals.uchicago.edu

Rothschild, B. M.; Martin, L. D.; Lev, G.; et al. (август 2001). „Mycobacterium tuberculosis complex DNA from an extinct bison dated 17,000 years before the present”. Clinical Infectious Diseases. 33 (3): 305—11. PMID 11438894. doi:10.1086/321886.

web.archive.org

„The sixteenth global report on tuberculosis” (PDF). 2011. Архивирано из оригинала 03. 02. 2013. г. Приступљено 21. 06. 2017.
World Health Organization (2009). „Epidemiology” (PDF). Global tuberculosis control: epidemiology, strategy, financing. стр. 6—33. ISBN 978-92-4-156380-2. Архивирано из оригинала 19. 04. 2009. г. Приступљено 12. 11. 2009.
Behera 2010, стр. 457. Behera, D. (2010). Textbook of pulmonary medicine (2. изд.). New Delhi: Jaypee Brothers Medical Pub. стр. 457—. ISBN 978-81-8448-749-7. Архивирано из оригинала 18. 7. 2013. г. Приступљено 14. 2. 2014.
Kabra 2006, стр. 249 Kabra, Vimlesh Seth, S.K., ур. (2006). Essentials of tuberculosis in children (3. изд.). New Delhi: Jaypee Bros. Medical Publishers. стр. 249—. ISBN 978-81-8061-709-6. Архивирано из оригинала 10. 11. 2014. г. Приступљено 14. 02. 2014.
„Vaccine and Immunizations: TB Vaccine (BCG)”. Centers for Disease Control and Prevention. 2011. Архивирано из оригинала 17. 11. 2011. г. Приступљено 26. 7. 2011.
„BCG Vaccine Usage in Canada -Current and Historical”. Public Health Agency of Canada. 2010. Архивирано из оригинала 30. 3. 2012. г. Приступљено 30. 12. 2011.
„The Global Plan to Stop TB”. World Health Organization. 2011. Архивирано из оригинала 12. 06. 2011. г. Приступљено 13. 6. 2011.
World Health Organization (2009). „The Stop TB Strategy, case reports, treatment outcomes and estimates of TB burden”. Global tuberculosis control: epidemiology, strategy, financing. стр. 187—300. ISBN 978-92-4-156380-2. Архивирано из оригинала 30. 10. 2013. г. Приступљено 14. 11. 2009.
„Global Tuberculosis Control 2011” (PDF). World Health Organization. Архивирано из оригинала 01. 04. 2014. г. Приступљено 15. 4. 2012.
World Health Organization. „WHO report 2008: Global tuberculosis control”. Архивирано из оригинала 16. 10. 2013. г. Приступљено 13. 4. 2009.
World Health Organization. „Global Tuberculosis Control Report, 2006 – Annex 1 Profiles of high-burden countries” (PDF). Архивирано из оригинала 05. 05. 2012. г. Приступљено 13. 10. 2006.
Hippocrates. „Aphorisms.”. Архивирано из оригинала 2005-02-11. г. Приступљено 7. октобра 2006. Проверите вредност парамет(а)ра за датум: |access-date= (помоћ)
Sledzik, Paul S.; Bellantoni, Nicholas. „Bioarcheological and biocultural evidence for the New England vampire folk belief” (PDF). American Journal of Physical Anthropology. 94 (2): 269—274. ISSN 0002-9483. PMID 8085617. doi:10.1002/ajpa.1330940210. Архивирано из оригинала (PDF) 4. 10. 2003. г. Приступљено 14. 2. 2014.
{{cite web|author= |url=http://edition.cnn.com/2004/TRAVEL/DESTINATIONS/02/26/mammoth.cave.ap/index.html |title=date= |website= |publisher= |access-date=|archive-date=13. 08. 2006 |archive-url=https://web.archive.org/web/20060813140746/http://edition.cnn.com/2004/TRAVEL/DESTINATIONS/02/26/mammoth.cave.ap/index.html |url-status= }} CNN. 27. фебруар 2004. Приступљено сајту 8. октобра 2006.
Lalloo UG, Naidoo R, Ambaram A (мај 2006). „Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis”. Curr Opin Pulm Med. 12 (3): 179—85. PMID 16582672. doi:10.1097/01.mcp.0000219266.27439.52. Архивирано из оригинала 10. 05. 2013. г. Приступљено 14. 02. 2014.
Bhargava, Anurag; Pinto, Lancelot; Pai, Madhukar (2011). „Mismanagement of tuberculosis in India: Causes, consequences, and the way forward”. Hypothesis. 9 (1): e7. Архивирано из оригинала 12. 01. 2020. г. Приступљено 14. 02. 2014.
Barder O, Kremer M, Williams H (2006). „Advance Market Commitments: A Policy to Stimulate Investment in Vaccines for Neglected Diseases”. The Economists' Voice. 3 (3). doi:10.2202/1553-3832.1144. Архивирано из оригинала 5. 11. 2006. г. Приступљено 14. 2. 2014.
Bill and Melinda Gates Foundation Announcement (2004). „Gates Foundation Commits $82.9 Million to Develop New Tuberculosis Vaccines”. Архивирано из оригинала 10. 10. 2009. г. Приступљено 14. 02. 2014.

who.int

„Tuberculosis Fact sheet N°104”. World Health Organization. новембар 2010. Приступљено 26. 7. 2011.
World Health Organization. „Global tuberculosis control–surveillance, planning, financing WHO Report 2006”. Приступљено 13. 10. 2006.
„WHO Disease and injury country estimates”. World Health Organization. 2004. Приступљено 11. 11. 2009.
World Health Organization (2009). „The Stop TB Strategy, case reports, treatment outcomes and estimates of TB burden”. Global tuberculosis control: epidemiology, strategy, financing. стр. 187—300. ISBN 978-92-4-156380-2. Архивирано из оригинала 30. 10. 2013. г. Приступљено 14. 11. 2009.
World Health Organization. „WHO report 2008: Global tuberculosis control”. Архивирано из оригинала 16. 10. 2013. г. Приступљено 13. 4. 2009.
„Frequently asked questions about TB and HIV”. World Health Organization. Приступљено 15. 4. 2012.
„Public-Private Partnership Announces Immediate 40 Percent Cost Reduction for Rapid TB Test” (pdf). World Health Organization. 6. 8. 2012.
Webber D, Kremer M (2001). „Stimulating Industrial R&D for Neglected Infectious Diseases: Economic Perspectives” (PDF). Bulletin of the World Health Organization. 79 (8): 693—801.

whonamedit.com

Léon Charles Albert Calmette на сајту Who Named It

wired.com

McKenna, Maryn (12. 1. 2012). „Totally Resistant TB: Earliest Cases in Italy”. Wired. Приступљено 12. 1. 2012.

wkhealth.com

meta.wkhealth.com

Lalloo UG, Naidoo R, Ambaram A (мај 2006). „Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis”. Curr Opin Pulm Med. 12 (3): 179—85. PMID 16582672. doi:10.1097/01.mcp.0000219266.27439.52. Архивирано из оригинала 10. 05. 2013. г. Приступљено 14. 02. 2014.

worldcat.org

Sledzik, Paul S.; Bellantoni, Nicholas. „Bioarcheological and biocultural evidence for the New England vampire folk belief” (PDF). American Journal of Physical Anthropology. 94 (2): 269—274. ISSN 0002-9483. PMID 8085617. doi:10.1002/ajpa.1330940210. Архивирано из оригинала (PDF) 4. 10. 2003. г. Приступљено 14. 2. 2014.